In this revealing episode, we delve deep into the inner workings of the government and their response to Sir Robert Francis KC's infected blood compensation study. We examine letters between the Paymaster General, Jeremy Quin and The Chancellor of the Exchequer ,Jeremy Hunt and more.

Bayer, a major pharmaceutical company, sold an infected blood product called Koate which was contaminated with HIV and Hepatitis. This infected product was distributed to countries worldwide, spreading two deadly diseases to unsuspecting patients. Bayer supplied Koate to multiple countries, including Canada, Italy, Japan, the UK and the United States. The product was made form human plasma, which had not been appropriately screened or heat-treated for infectious diseases like Hepatitis B, Hepatitis C and HIV. Because of this, thousands of people were infected by these catastrophic illnesses when they received infusions of this tainted blood product. At the time, Bayer had marketed Koate as an effective solution for treating hemophilia; however, it failed to adequately disclose its potential risks or warn customers about its contamination levels. Despite the dangers being well known to the manufacturer and health authorities, Bayer continued distributing Koate without proper safety protocols through the mid-1980s. The consequences of this preventable disaster are still felt today as many who were infected with HIV or Hepatitis through contaminated Koate have since passed away due to related illnesses or complications. Additionally, those lucky enough to survive continue facing challenges associated with chronic diseases and healthcare costs. Bayer’s failure and negligence impacted countless lives worldwide and serves as a reminder of the need for stringent safety standards when dealing with potentially hazardous substances like blood products. Companies should always value human life over profit margins; otherwise, such scenarios can become a global health crisis, as seen with Koate in the 1970s and 1980s.

On the 7th March 2023, Paymaster General Jeremy Quin met with a group of individuals who had been impacted by the infected blood scandal. This meeting was highly anticipated by those affected, as they were eager to hear what Mr. Quin had to say about the progress of work regarding the infected blood compensation framework. However, many were left disappointed after the meeting. In this video, we discuss what happened during the meeting and why some people felt let down by it.

The Infected Blood Inquiry is ending, and a second interim report on compensation from inquiry chairman Sir Brian Langstaff is due to be published before Easter. In this episode, Jason discusses the timing of the second interim report, the implications, and what lies further ahead for the campaign.

The Infected Blood Inquiry is coming to a close, with final submissions from interested parties beginning on January 17th. The inquiry was set up to investigate how contaminated blood products were allowed into the NHS, and led to thousands of people being infected with HIV and hepatitis C.  In this episode, Jason looks at some of the closing written submissions submitted to the Inquiry ahead of next week's hearings. The department of health seems to be blaming hindsight bias and comparing the scandal to a maze. Counsel to the Inquiry issues a note regarding parliamentary privilege, which could have significant ramifications for the Inquiry's final findings.